The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PRIMUS-002: A multicentre, open-label, phase II study examining FOLFOX and nab-paclitaxel (FA) and nab-paclitaxel and gemcitabine (AG) as neoadjuvant therapy for (borderline) resectable pancreatic cancer (PC), focusing on biomarker and liquid biopsy development.
 
Derek B. Grose
No Relationships to Disclose
 
Colin J McKay
No Relationships to Disclose
 
Susie Cooke
No Relationships to Disclose
 
Janet Shirley Graham
No Relationships to Disclose
 
Fraser Duthie
No Relationships to Disclose
 
Nigel Jamieson
No Relationships to Disclose
 
Reena Ravikumar
No Relationships to Disclose
 
Aileen Duffton
No Relationships to Disclose
 
David McIntosh
Honoraria - Ipsen; Novartis
Speakers' Bureau - Ipsen; Novartis
 
Rebecca Goody
No Relationships to Disclose
 
Ganesh Radhakrishna
No Relationships to Disclose
 
Maria A Hawkins
No Relationships to Disclose
 
Dave Colville
No Relationships to Disclose
 
Christine Willshire
No Relationships to Disclose
 
Jon Stobo
No Relationships to Disclose
 
James Paul
No Relationships to Disclose
 
Sarah Bradley
No Relationships to Disclose
 
Judith Dixon-Hughes
No Relationships to Disclose
 
Andrew Victor Biankin
No Relationships to Disclose
 
David Kuang-Fu Chang
No Relationships to Disclose